![PDF) Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up PDF) Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up](https://i1.rgstatic.net/publication/276456184_Advanced_hepatocellular_carcinoma_and_sorafenib_Diagnosis_indications_clinical_and_radiological_follow-up/links/5bb3491592851ca9ed33fe9d/largepreview.png)
PDF) Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up
![PDF) In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer PDF) In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer](https://www.researchgate.net/publication/303535657/figure/fig1/AS:365993659518977@1464271096497/llustration-of-sorafenib-loaded-nanomedicines_Q320.jpg)
PDF) In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer
![Symmetry | Free Full-Text | Synthesis, Optical and DFT Characterizations of Laterally Fluorinated Phenyl Cinnamate Liquid Crystal Non-Symmetric System Symmetry | Free Full-Text | Synthesis, Optical and DFT Characterizations of Laterally Fluorinated Phenyl Cinnamate Liquid Crystal Non-Symmetric System](https://www.mdpi.com/symmetry/symmetry-13-01145/article_deploy/html/images/symmetry-13-01145-sch002-550.jpg)
Symmetry | Free Full-Text | Synthesis, Optical and DFT Characterizations of Laterally Fluorinated Phenyl Cinnamate Liquid Crystal Non-Symmetric System
H C C P h as e III Pr ot oc ol TS -1 0 4 Y E S -P , V ersi o n 3. 0 1 Bi oc o m p ati bl es C O N FI D E N TI AL 8 A u g ust 2
![Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review - ScienceDirect Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1558767316300106-gr1.jpg)
Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review - ScienceDirect
![PDF) SP94-Targeted Nanoparticles Enhance the Efficacy of Sorafenib and Improve Liver Cancer Cell Discrimination PDF) SP94-Targeted Nanoparticles Enhance the Efficacy of Sorafenib and Improve Liver Cancer Cell Discrimination](https://www.researchgate.net/profile/Cameron-Evans-3/publication/348093444/figure/fig2/AS:1101118306287617@1639538470547/Cell-viability-assay-of-A-Hep3B-treated-with-sorafenib-control-sorafenib-NPs_Q320.jpg)
PDF) SP94-Targeted Nanoparticles Enhance the Efficacy of Sorafenib and Improve Liver Cancer Cell Discrimination
![PDF) Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma PDF) Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma](https://i1.rgstatic.net/publication/5895054_Phase_II_Study_to_Investigate_the_Efficacy_Safety_and_Pharmacokinetics_of_Sorafenib_in_Japanese_Patients_with_Advanced_Renal_Cell_Carcinoma/links/53d5a0a20cf228d363ea0d95/largepreview.png)